Profil
David F.
Wurtman was the founder of Lyric Pharmaceuticals, Inc., founded in 2013, where the titles held included President, Chief Executive Officer & Director from 2013 to 2018.
The current job is Director at GlycoMira Therapeutics, Inc. Former jobs include Principal at Protein Design Labs, Inc., Principal at Genzyme Corp., Vice President-International Business at ChinaBio LLC, Executive Vice President-Strategic Projects at PAVmed, Inc., Principal at EOS Biotechnology, Inc., VP-Medical Affairs & Product Development at Kineta, Inc. (Washington), and Chief Medical Officer at Lucid Diagnostics, Inc. from 2019 to 2022.
Education includes an MBA from Massachusetts Institute of Technology and a doctorate from Harvard Mit Health Sciences & Technology.
Postes actifs de David F. Wurtman
| Sociétés | Poste | Début |
|---|---|---|
GlycoMira Therapeutics, Inc.
GlycoMira Therapeutics, Inc. BiotechnologyHealth Technology Develops glycosaminoglycan-based therapeutics | Directeur/Membre du Conseil | - |
Anciens postes connus de David F. Wurtman
| Sociétés | Poste | Fin |
|---|---|---|
| LUCID DIAGNOSTICS INC. | Directeur Technique/Scientifique/R&D | 31/03/2022 |
Lyric Pharmaceuticals, Inc.
Lyric Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops novel gastrointestinal therapeutics | Fondateur | 01/08/2018 |
Kineta, Inc. (Washington)
Kineta, Inc. (Washington) Pharmaceuticals: MajorHealth Technology Develops drugs that modulate and enhance the human immune system | Directeur Technique/Scientifique/R&D | - |
| PAVMED INC. | Corporate Officer/Principal | - |
Protein Design Labs, Inc.
Protein Design Labs, Inc. Pharmaceuticals: MajorHealth Technology Develops humanized monoclonal antibodies | Corporate Officer/Principal | - |
Formation de David F. Wurtman
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 11 |
|---|---|
Protein Design Labs, Inc.
Protein Design Labs, Inc. Pharmaceuticals: MajorHealth Technology Develops humanized monoclonal antibodies | Health Technology |
Genzyme Corp.
Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Health Technology |
ChinaBio LLC
ChinaBio LLC Financial ConglomeratesFinance Operates as an investment, consulting and media company which helps life science companies | Finance |
PAVmed, Inc.
PAVmed, Inc. Medical SpecialtiesHealth Technology Develops and commercializes medical devices | Health Technology |
Lyric Pharmaceuticals, Inc.
Lyric Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops novel gastrointestinal therapeutics | Health Technology |
EOS Biotechnology, Inc.
EOS Biotechnology, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutic and diagnostic drugs | Health Technology |
Massachusetts Institute of Technology
Massachusetts Institute of Technology Finance/Rental/LeasingFinance Functions as a College/University | Finance |
Kineta, Inc. (Washington)
Kineta, Inc. (Washington) Pharmaceuticals: MajorHealth Technology Develops drugs that modulate and enhance the human immune system | Health Technology |
Harvard Mit Health Sciences & Technology
Harvard Mit Health Sciences & Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
GlycoMira Therapeutics, Inc.
GlycoMira Therapeutics, Inc. BiotechnologyHealth Technology Develops glycosaminoglycan-based therapeutics | Health Technology |
Lucid Diagnostics, Inc.
Lucid Diagnostics, Inc. Medical SpecialtiesHealth Technology Develops medical testing devices | Health Technology |
















